The use of otic powder in the treatment of acute external otitis

David Goldenberg1, Avishay Golz, Aviram Netzer

  • 1Department of Otolaryngology-Head and Neck Surgery, Rambam Medical Center, and Technion Faculty of Medicine, Haifa, Israel. g.david@tx.technion.ac.il

Abstract

Insights

Auricularum powder demonstrated rapid and effective treatment for acute external otitis (AEO). While ciprofloxacin and tobramycin drops were also effective, Auricularum powder showed quicker symptom relief for AEO patients.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Dermatology

Background:

  • Acute external otitis (AEO) is a common ear infection caused by bacteria like Pseudomonas aeruginosa and Staphylococcus aureus.
  • Standard treatments involve topical antimicrobials and steroids, alongside moisture prevention and canal cleansing.

Purpose of the Study:

  • To compare the efficacy of a topical otic powder (Auricularum) with ciprofloxacin and tobramycin drops for treating AEO.

Main Methods:

  • A randomized prospective trial involving 120 adult patients diagnosed with AEO.
  • Patients received either Auricularum powder, ciprofloxacin drops, or tobramycin drops for 14 days.
  • Inclusion criteria ensured no prior treatment, no drug sensitivities, and no tympanic membrane perforation.

Main Results:

  • 86% of patients treated with Auricularum powder were cured by days 3-4, compared to 77% with ciprofloxacin and 56% with tobramycin.
  • All patients across all treatment groups achieved a cure by day 14.

Conclusions:

  • Auricularum powder offers an effective and rapid treatment option for AEO.
  • Ciprofloxacin drops provided quick symptom relief, while tobramycin drops were effective but slower acting.